Taysha Gene Therapies, Inc. (TSHA)
6.015
-0.18
(-2.98%)
USD |
NASDAQ |
Aug 26, 16:00
6.015
0.00 (0.00%)
After-Hours: 18:15
Taysha Gene Therapies Market Cap : 1.957B for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 2.017B |
| August 24, 2026 | 1.942B |
| August 21, 2026 | 1.981B |
| August 20, 2026 | 1.988B |
| August 19, 2026 | 2.092B |
| August 18, 2026 | 2.014B |
| August 17, 2026 | 2.020B |
| August 14, 2026 | 1.936B |
| August 13, 2026 | 1.949B |
| August 12, 2026 | 2.084B |
| August 11, 2026 | 2.173B |
| August 10, 2026 | 2.072B |
| August 07, 2026 | 2.134B |
| August 06, 2026 | 1.821B |
| August 05, 2026 | 1.856B |
| August 04, 2026 | 1.781B |
| August 03, 2026 | 1.660B |
| July 31, 2026 | 1.683B |
| July 30, 2026 | 1.688B |
| July 29, 2026 | 1.612B |
| July 28, 2026 | 1.569B |
| July 27, 2026 | 1.592B |
| July 24, 2026 | 1.586B |
| July 23, 2026 | 1.675B |
| July 22, 2026 | 1.626B |
| Date | Value |
|---|---|
| July 21, 2026 | 1.629B |
| July 20, 2026 | 1.603B |
| July 17, 2026 | 1.712B |
| July 16, 2026 | 1.715B |
| July 15, 2026 | 1.778B |
| July 14, 2026 | 1.637B |
| July 13, 2026 | 1.546B |
| July 10, 2026 | 1.821B |
| July 09, 2026 | 1.887B |
| July 08, 2026 | 1.864B |
| July 07, 2026 | 1.867B |
| July 06, 2026 | 1.833B |
| July 02, 2026 | 1.876B |
| July 01, 2026 | 1.910B |
| June 30, 2026 | 1.956B |
| June 29, 2026 | 1.933B |
| June 26, 2026 | 1.821B |
| June 25, 2026 | 1.784B |
| June 24, 2026 | 1.994B |
| June 23, 2026 | 1.971B |
| June 22, 2026 | 1.876B |
| June 18, 2026 | 1.844B |
| June 17, 2026 | 1.778B |
| June 16, 2026 | 1.681B |
| June 15, 2026 | 1.715B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Altimmune, Inc. | 613.57M |
| Protalix Biotherapeutics, Inc. | 199.41M |
| Humacyte, Inc. | 190.35M |
| Agenus, Inc. | 351.37M |
| Amgen, Inc. | 238.03B |
Market Cap Related Metrics
| PS Ratio | 376.70 |
| PEG Ratio | -0.6597 |
| Price to Book Value | 5.053 |
| Price | 6.015 |
| Earnings Yield | -7.19% |
| PEGY Ratio | -0.6597 |